亿帆医药：9月5日召开董事会会议

Group 1 - Yifan Pharmaceutical (SZ 002019) held its first extraordinary board meeting of the ninth session on September 5, 2025, to discuss the election of the chairman and other related matters [1] - For the first half of 2025, Yifan Pharmaceutical's revenue composition was as follows: pharmaceuticals accounted for 85.53%, pharmaceutical raw materials and intermediates accounted for 11.47%, and high polymer materials accounted for 3.0% [1] - As of the report date, Yifan Pharmaceutical's market capitalization was 19 billion yuan [1] Group 2 - Haidilao is diversifying its business with initiatives such as opening a bakery by West Lake and entering the high-end hotel sector, but the survival rate of its sub-brands is less than 50% [1]